KEAP1 and fibrosis: Overall, our data showed that cardiomyocyte-specific activation of NRF2 via knockout of Keap1 protects the heart against pressure overload-induced cardiomyocyte cell death, cardiac fibrosis, and contractile dysfunction but without significantly affecting the extent of hypertrophy.